Nilutamide
Title: Nilutamide
CAS Registry Number: 63612-50-0
CAS Name: 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione
Additional Names: 1-(3¢-trifluoromethyl-4¢-nitrophenyl)-4,4-dimethylimidazoline-2,5-dione
Manufacturers' Codes: RU-23908
Trademarks: Anandron (Cassenne); Nilandron (Aventis)
Molecular Formula: C12H10F3N3O4
Molecular Weight: 317.22
Percent Composition: C 45.43%, H 3.18%, F 17.97%, N 13.25%, O 20.17%
Literature References: Nonsteroidal antiandrogen. Prepn: J. Perronnet et al., DE 2649925; eidem, US 4097578 (1977, 1978 both to Roussel-UCLAF). Pharmacology: J.-P. Raynaud et al., J. Steroid Biochem. 11, 93 (1979). Review of kinetics, metabolism and clinical studies: idem et al., Prog. Clin. Biol. Res. 185A, 99-120 (1985); of therapeutic efficacy in prostate cancer: M. G. Harris et al., Drugs Aging 3, 9-25 (1993).
Properties: Crystals from ethanol, mp 149°. Freely sol in ethyl acetate, acetone, chloroform, ethanol, dichloromethane, methanol. Soly in water at 25°: < 0.1%.
Melting point: mp 149°
Therap-Cat: Antineoplastic (hormonal).
Keywords: Antiandrogen; Antineoplastic (Hormonal); Antiandrogens.

Others monographs:
Certolizumab PegolGlatiramerConvallariaOpianic Acid
Nickel SesquioxideGraphite1H-PyrroleChlorpromazine
Potassium Tetrachloroaurate(III)FlucarbazoneAzatadineTiaramide
LomefloxacinAmiodaroneBenzidineHanatoxins
©2016 DrugLead US FDA&EMEA